About Us

Sundeep has over 35 years of experience in small-molecule drug discovery and development in oncology, inflammation, the central nervous system, cardiovascular, neuromuscular and metabolic disorders. He is a co-inventor of Zetia® (ezetimibe) and Vytorin® (ezetimibe/simvastatin).

Besides distinguished tenures at companies like Schering-Plough Research Institute, Bristol-Myers Squibb, and Johnson & Johnson, Sundeep has been founder / co-founder at a number of innovative pharmaceutical research startups including Cardero Therapeutics, Epirium, Sphaera Pharma, Aayam Therapeutics, Pacegenix and Nurogenix. 

Sundeep’s latest mission-based venture, BlueOakNx, brings to market a product that leverages his seminal discovery of a natural flavonol that mimics the mechanism of action of a new endogenous steroid produced by mitochondria during exercise that he proposed, and subsequently led its discovery and detection in humans. This endogenous steroid induces mitochondrial biogenesis and also protects mitochondria. The discovery is the result of more than 15 years of research and has led to a new approach to support mitochondria levels and function.

Sundeep received the American Chemical Society’s  2004 Heroes of Chemistry Award and also 2005 National Inventor of the Year. He is co-author of 70+ publications and presentations, and co-inventor on 100+ issued and applied patents. Sundeep has also served as Trustee of the University of California Davis Foundation, Advisory Board of the Deans’ Council at University of California Davis and on the Graduate Studies Advisory Board and gives his time in support of students at the University of California at Davis, his Alma Mater.

Learn more about Sundeep - Linkedin